Signal transducer and activator of transcription 5B (STAT5B) modulates adipocyte differentiation via MOF

Cellular Signalling

Volumn 27, Issue 12, 2015, Pages 2434-2443

  Gao, Peng ^a   Zhang, Yuchao ^a,b   Liu, Yuantao ^c   Chen, Jicui ^a   Zong, Chen ^a   Yu, Cong ^a   Cui, Shang ^a   Gao, Weina ^a   Qin, Dandan ^a   Sun, Wenchuan ^d   Li, Xia ^a   Wang, Xiangdong ^a,e  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c QINGDAO MUNICIPAL HOSPITAL   (China)

^d THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^e SHANDONG UNIVERSITY   (China)

Author keywords

Adipogenesis; C EBP ; MOF; Obesity; STAT5B

Indexed keywords

ACYLTRANSFERASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID BINDING PROTEIN 4; MALES ABSENT ON THE FIRST PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT5B PROTEIN; UNCLASSIFIED DRUG; HISTONE ACETYLTRANSFERASE; MOF PROTEIN, MOUSE; PROTEIN BINDING; STAT5 PROTEIN; STAT5B PROTEIN, MOUSE;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HELA CELL LINE; HUMAN; HUMAN CELL; MALE; MOF GENE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; STAT5B GENE; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; GENETICS; INTRAABDOMINAL FAT; LIPID DIET; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; TRANSCRIPTION INITIATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BASE SEQUENCE; DIET, HIGH-FAT; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; INTRA-ABDOMINAL FAT; MICE; MICE, INBRED C57BL; OBESITY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84942284441     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.09.010     Document Type: Article

References (36)

1. Friedman J.M. Obesity in the new millennium. Nature 2000, 404:632-634.
2. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004, 116:337-350.
3. Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3:35-42.
4. Hoffman A.R., Biller B.M., Cook D., Baptista J., Silverman B.L., Dao L., Attie K.M., Fielder P., Maneatis T., Lippe B. Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J. Clin. Endocrinol. Metab. 2005, 90(12):6431-6440.
5. Cenci M.C., Conceição F.L., Soares D.V., Spina L.D., Brasil R.R., Lobo P.M., Michmacher E., Vaisman M. Impact of 5years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults. Metabolism 2008, 57(1):121-129.
6. Donahue L.R., Beamer W.G. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 1993, 136(1):91-104.
7. Takahashi J., Furuhata Y., Ikeda A., Takahashi M., Iwata H., Kazusaka A., Fujita S. Characterization of hepatic cytochrome P450 isozyme composition in the transgenic rat expressing low level human growth hormone. Xenobiotica 1999, 29(12):1203-1212.
8. Frank S.J., Wang X., He K., Yang N., Fang P., Rosenfeld R.G., Hwa V., Chaudhuri T.R., Deng L., Zinn K.R. In vivo imaging of hepatic growth hormone signaling. Mol. Endocrinol. 2006, 20(11):2819-2830.
9. Rowland J.E., Lichanska A.M., Kerr L.M., White M., d'Aniello E.M., Maher S.L., Brown R., Teasdale R.D., Noakes P.G., Waters M.J. In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol. Cell. Biol. 2005, 25(1):66-77.
10. Richter H.E., Albrektsen T., Billestrup N. The role of signal transducer and activator of transcription5 in the inhibitory effects of GH on adipocyte differentiation. J. Mol. Endocrinol. 2003, 30:139-150.
11. Miyaoka Y., Tanaka M., Naiki T., Miyajima A. Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways. J. Biol. Chem. 2006, 281:37913-37920.
12. Song H.Y., Jeon E.S., Kim J.I., Jung J.S., Kim J.H. Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells. J. Cell. Biochem. 2007, 101:1238-1251.
13. Richard A.J., Stephens J.M. The role of JAK-STAT signaling in adipose tissue function. Biochim. Biophys. Acta 2014, 1842(3):431-439.
14. Kanda K., Nishi K., Kadota A., Nishimoto S., Liu M.C., Sugahara T. Nobiletin suppresses adipocyte differentiation of 3 T3-L1 cells by an insulin and IBMX mixture induction. Biochim. Biophys. Acta 2012, 1820(4):461-468.
15. Zhao L., Wang A., Corl B.A., Jiang H. Effect of growth hormone on the differentiation of bovine preadipocytes into adipocytes and the role of the signal transducer and activator of transcription 5b. J. Anim. Sci. 2014, 92(5):1958-1967.
16. Yarwood S.J., Sale E.M., Sale G.J., Houslay M.D., Kilgour E., Anderson N.G. Growth hormone dependent differentiation of 3 T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70S6 kinase signaling. J. Biol. Chem. 1999, 274:8662-8668.
17. Kawai M., Namba N., Mushiake S., Etani Y., Nishimura R., Makishima M., Ozono K. Growth hormone stimulates adipogenesis of 3 T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J. Mol. Endocrinol. 2007, 38:19-34.
18. Hilfiker A., Hilfiker-Kleiner D. Pannuti A, and Lucchesi JC: mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J. 1997, 16:2054-2060.
19. Kapoor-Vazirani P., Kagey J.D., Powell D.R., Vertino P.M. Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity. Cancer Res. 2008, 68(16):6810-6821.
20. Mellert H.S., McMahon S.B. hMOF, a KAT (8) with many lives. Mol. Cell 2009, 36(2):174-175.
21. Thomas T., Dixon M.P., Kueh A.J., Voss A.K. Mof (MYST1 or KAT8) is essential for progression of embryonic development past the blastocyst stage and required for normal chromatin architecture. Mol. Cell. Biol. 2008, 28(16):5093-5105.
22. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 2005, 37(4):391-400.
23. Miller K.K., Wexler T., Fazeli P., Gunnell L., Graham G.J., Eleswarapu S., Gu Z.Z., Jiang H.H. Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by MultipleDistal signal transducer and activator of transcription 5 binding sites. Endocrinology 2008, 149(5):2230-2240.
24. Gao F., Wang W. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a. Mol. Med. Rep. 2014, 11(2):1200-1206.
25. Zhang Y., Liu Y., Li X., Gao W., Zhang W., Guan Q., Jiang J., Frank S.J., Wang X. Effects of insulin and IGF-I on growth hormone-induced STAT5 activation in 3 T3-F442A adipocytes. Lipids Health Dis. 2013, 10.1186/1476-511X-12-56.
26. Bao J., Li D., Wang L., Wu J., Hu Y., Wang Z., Chen Y., Cao X., Jiang C., Yan W., Xu C. MicroRNA-449 and MicroRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway. J. Biol. Chem. 2012, 287(26):21686-21698.
27. Taipale M., Rea S., Richter K., Vilar A., Lichter P., Imhof A., Akhtar A. hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol. Cell. Biol. 2005, 25(15):6798-6810.
28. Stephens J.M., Morrison R.F., Pilch P.F. The expression and regulation of STATs during 3 T3-L1 adipocyte differentiation. J. Biol. Chem. 1996, 271(18):10441-10444.
29. Stewart W.C., Morrison R.F., Young S.L., Stephens J.M. Regulation of signal transducers and activators of transcription (STATs) by effectors of adipogenesis: coordinate regulation of STATs1, 5A, and 5B with peroxisome proliferator-activated receptor-gamma and C/AAAT enhancer binding protein-alpha. Biochim. Biophys. Acta 1999, 1452:188-196.
30. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, Roles in Cytokine Responses. Cell 1998, 93(5):841-850.
31. Floyd Z.E., Jacqueline M. Stephens: STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes 2003, 52:2308-2314.
32. Stewart W.C.,., Baugh J.E.,., Floyd Z.E., Stephensb J.M. STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3 T3-L1 cells. Biochem. Biophys. Res. Commun. 2004, 324(1):355-359.
33. Smith E.R., Cayrou C., Huang R., Lane W.S., Cote J., Lucchesi J.C. A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol. Cell. Biol. 2005, 25:9175-9188.
34. Li X., Wu L., Corsa C.A., Kunkel S., Dou Y. Two mammalian MOF complexes regulate transcription activation by distinct mechanisms. Mol. Cell 2009, 36(2):290-301. 10.1016/j.molcel.2009.07.031.
35. Lu L., Lei L., Xiang L., Wu X.-S., Liu D.-P., Liang C.C.-C.C. Modulations of hMOF autoacetylation by SIRT1 regulate hMOF recruitment and activities on the chromatin. Cell Res. 2011, 21:1182-1195.
36. Louet J.F., Coste A., Amazit L., Tannour-Louet M., Wu R.C., Tsai S.Y., Tsai M.J., Auwerx J., O'Malley B.W. Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program. Proc. Natl. Acad. Sci. 2006, 103(47):17868-17873.